Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

Insights Imaging. 2024 May 12;15(1):117. doi: 10.1186/s13244-024-01706-8.
No abstract available

Publication types

  • Published Erratum